XAnge leads €2.5m round for Synapse Medicine

Kima Ventures and BNP Paribas Développement also took part in the investment.

The startup plans to use the fresh funding to strengthen its team by recruiting data scientists able to optimise its pharma database, develop new features across the platform, and further expand in France and subsequently launch in the US.

XAnge is currently investing via its XAnge Digital 3 fund, which held a final close on €90m in May 2018. The vehicle focuses on early-stage investments in startups operating in the digital consumer, enterprise data and fintech sectors, mainly based in France and Germany.

Company
Founded in 2017 and based in Bordeaux, Synapse Medicine is an online platform that provides doctors with virtual medical assistance and information pertinent to their patients and prescriptions. The platform uses AI, algorithms and machine learning to analyse more than 30,000 referenced medical documents, scan thousands of files, and translate the information obtained into a large database accessible through the app.

People
XAnge Private Equity – Guillaume Meulle (managing partner).
Synapse Medicine – Clément Goehrs, Louis Letinier, Bruno Thiao-Layel (co-founders).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• France
• Healthcare
• Technology
• XAnge Private Equity
• Venture
• Kima Ventures
• BNP Paribas Développement
• France